Cote d'Ivoire vs Gambia: Cause of death, by non-communicable diseases, male
Cote d'Ivoire
34.6%
in 2021
Gambia
35.2%
in 2021
Cote d'Ivoire rank
153rd
Gambia rank
150th
Cause of death, by non-communicable diseases, male over time
- Cote d'Ivoire
- Gambia
How they compare
Gambia currently reports 35.2% against 34.6% in Cote d'Ivoire, a difference of 0.6%.
Across all 6 years both countries report, Gambia has been ahead every year.
Cote d'Ivoire ranks 153rd and Gambia ranks 150th of 185 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.8% | 30.4% | 12.6% | Gambia |
| 2010s | 31.9% | 37.2% | 5.3% | Gambia |
| 2020s | 35.3% | 37.5% | 2.2% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Cote d'Ivoire or Gambia?
- Gambia, at 35.2% against 34.6% in Cote d'Ivoire as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Cote d'Ivoire and Gambia?
- 0.6%, with Gambia ahead.
- How many years of comparable data are there for Cote d'Ivoire and Gambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and Gambia rank globally for cause of death, by non-communicable diseases, male?
- Cote d'Ivoire ranks 153rd and Gambia ranks 150th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.